Shak Steven 4
4 · GENOMIC HEALTH INC · Filed Jul 10, 2019
Insider Transaction Report
Form 4
Shak Steven
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-07-08$57.76/sh−4,048$233,814→ 208,795 total(indirect: By Trust) - Sale
Common Stock
2019-07-09$56.27/sh−17,200$967,909→ 191,595 total(indirect: By Trust) - Sale
Common Stock
2019-07-08$56.97/sh−20,952$1,193,570→ 212,843 total(indirect: By Trust) - Sale
Common Stock
2019-07-09$57.06/sh−7,800$445,034→ 183,795 total(indirect: By Trust)
Footnotes (7)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 5, 2019.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $56.55 to $57.535.
- [F4]Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F5]Represents weighted average sale price. Actual sale prices ranged from $57.555 to $58.01.
- [F6]Represents weighted average sale price. Actual sale prices ranged from $55.78 to $56.76.
- [F7]Represents weighted average sale price. Actual sale prices ranged from $56.82 to $57.30.